Status:
COMPLETED
Non-mass Enhancement in Breast MRI
Lead Sponsor:
Assiut University
Conditions:
Breast Neoplasm
Eligibility:
FEMALE
33-70 years
Brief Summary
Breast Magnetic Resonance Imaging (MRI) has been proven to be the most sensitive method in detection of breast cancer with sensitivity reaching 68-100%. The most frequent indication for breast MRI is ...
Eligibility Criteria
Inclusion
- all female with mean age 50 ± 17 having breast MRI
Exclusion
- Contraindications of MRI as pacemakers, aneurysmal clipping, retained metallic foreign bodies, or claustrophobic patients
- Pregnant women especially in the first trimester.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04083027
Start Date
March 1 2020
End Date
September 1 2021
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals
Asyut, Egypt, 71515